'Israel a world power in medical devices'

Rambam head says Israel is known around the world for its breakthroughs and imaginative applications in medicine.

By JUDY SIEGEL
December 5, 2011 06:02
1 minute read.
RAFAEL BEYAR

RAFAEL BEYAR. (photo credit: (Courtesy/Rambam Health Care)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

This country is a world power in the development of medical devices in the cardiovascular field, according to Rambam Medical Center director- general Prof. Rafael Beyar.

He made these comments at the ICI-Innovations in Cardiovascular Interventions conference – that he is co-chairing – which opened at Tel Aviv’s David Intercontinental Hotel on Sunday.

Be the first to know - Join our Facebook page.


Beyar – who himself is a leading interventional cardiologist (performing angioplasty and other minimally invasive diagnostic and treatment procedures) – said that Israel is known around the world for its breakthroughs and imaginative applications in medicine in general and the cardiovascular field in particular.

According to statistics, 56 percent of the local life sciences industry is devoted to the development of medical equipment, 20% to biotechnology and 12% to drug development. Medical equipment innovation deals primarily with implants and single- use equipment such as stents and artificial heart valves and devices to open clogged arteries.

There are 212 Israeli companies involved in developments in medical technology; 82 of them work solely in cardiovascular devices. Israel is highly respected as as innovator in medicine.

“If Israel were compared to Silicon Valley in California, it has about the same number of residents and also the same number of companies in the life sciences,” said Beyar.

“Israel invents and develops medical devices at the highest level, but with one small difference – Silicon Valley companies have a budget 20 times larger than that of Israeli companies,” he continued.



The combination of academia, industry and hospitals is the secret combination to development in the field, Beyar continued. The world’s medical equipment industry comprises $200 billion, when half of that amount is utilized in the US alone. Some 35% of that amount goes to the cardiovascular field.

Israeli medical equipment exports totaled $1.5 billion last year, an increase of 9% over 2009. Between January and September of this year alone, the figure rose by 15% to $1.2 billion.

Some 1,000 experts from Israel and abroad are attending the three-day meeting.

They include cardiologists, radiologists, electro-physiologists and representatives of huge companies.

Related Content

Lab
August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice

By JUDY SIEGEL-ITZKOVICH